Timing of COVID-19 Vaccine in the Setting of Anti-CD20 Therapy: A Primer for Nephrologists

被引：17
|
作者：
Kant, Sam [1 ]
Kronbichler, Andreas [2 ]
Salas, Antonio [1 ]
Bruchfeld, Annette [3 ,4 ]
Geetha, Duvuru [1 ]
机构：
[1] Johns Hopkins Univ, Sch Med, Dept Med, Div Nephrol, Baltimore, MD 21205 USA
[2] Med Univ Innsbruck, Dept Internal Med Nephrol & Hypertens 4, Innsbruck, Austria
[3] Karolinska Univ Hosp, Dept Renal Med, Stockholm, Sweden
[4] CLINTEC Karolinska Inst, Stockholm, Sweden
来源：
KIDNEY INTERNATIONAL REPORTS | 2021年 / 6卷 / 05期
关键词：
anti-CD20; COVID-19; vaccine;
D O I：
10.1016/j.ekir.2021.03.876
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1197 / 1199
页数：3
相关论文
共 50 条
  • [1] Outcomes in Patients with Hematological Malignancies Receiving Anti-CD20 Therapy in the Setting of COVID-19 Infection
    Lopez, Carlos A.
    Chitty, David
    Chi, Jeffrey
    Saif, Wasif
    Goldberg, Bradley
    BLOOD, 2020, 136
  • [2] Immunological Response to COVID-19 Vaccine Boosters in Multiple Sclerosis Patients Treated with anti-CD20 Therapy
    De Oliveira, Antonia
    Lei, Joyce
    Liu, Jiayuan
    Roche, Morgan
    Lin, Jerry
    Alfonso, Roberto
    Sadiq, Saud
    NEUROLOGY, 2023, 100 (17)
  • [3] Nucleocapsid Antigenemia in Patients Receiving Anti-CD20 Therapy With Protracted COVID-19
    Wilber, Eli
    Piantadosi, Anne
    Babiker, Ahmed
    McLendon, Kaleb
    O'Sick, William
    Fitts, Eric
    Webster, Andrew S.
    Verkerke, Hans
    Kim, James S.
    Phadke, Varun K.
    Rouphael, Nadine
    Titanji, Boghuma K.
    Blake, William T.
    Howard-Anderson, Jessica
    Roback, John D.
    Lam, Wilbur A.
    Damhorst, Gregory L.
    OPEN FORUM INFECTIOUS DISEASES, 2022, 9 (08):
  • [4] Longitudinal COVID-19 immune trajectories in autoimmune patients on anti-CD20 therapy
    Bazzi, S.
    Maguire, C.
    Holay, N.
    Geltman, J.
    Hurley, K.
    Ehrlich, L.
    Triplett, T.
    Melamed, E.
    MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (3_SUPPL) : 230 - 230
  • [5] Longitudinal COVID-19 immune trajectories in patients with neurological autoimmunity on anti-CD20 therapy
    Bazzi, Sam A.
    Maguire, Cole
    Holay, Nisha
    Geltman, Janelle
    Hurley, Kerin
    DiPasquale, Chris
    Abigania, Melissa
    Olson, Eric
    Ehrlich, Lauren I. R.
    Triplett, Todd A.
    Melamed, Esther
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2022, 68
  • [6] Longitudinal COVID-19 immune trajectories in patients with neurological autoimmunity on anti-CD20 therapy
    Bazzi, Sam A.
    Maguire, Cole
    Holay, Nisha
    Geltman, Janelle
    Hurley, Kerin
    DiPasquale, Chris
    Abigania, Melissa
    Olson, Eric
    Ehrlich, Lauren I. R.
    Triplett, Todd A.
    Melamed, Esther
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2022, 68
  • [7] COVID-19 mRNA Vaccine in Patients With Lymphoid Malignancy or Anti-CD20 Antibody Therapy: A Systematic Review and Meta-Analysis
    Ito, Yusuke
    Honda, Akira
    Kurokawa, Mineo
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 (08): : E691 - E707
  • [8] Anti-CD20 immunosuppressive disease-modifying therapies and COVID-19
    Giovannoni, Gavin
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2020, 41
  • [9] COVID-19 in Children with Nephrotic Syndrome on Anti-CD20 Chronic Immunosuppression
    Angeletti, Andrea
    Drovandi, Stefania
    Sanguineri, Francesca
    Santaniello, Maria
    Ferrando, Giulia
    Forno, Roberto
    Cipresso, Gaia
    Caridi, Gianluca
    Riella, Leonardo V.
    Cravedi, Paolo
    Ghiggeri, Gian Marco
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2020, 15 (10): : 1494 - 1495
  • [10] Prolonged viral pneumonia and high mortality in COVID-19 patients on anti-CD20 monoclonal antibody therapy
    Eeva Feuth
    Valtteri Nieminen
    Antti Palomäki
    Juha Ranti
    Marcus Sucksdorff
    Taru Finnilä
    Jarmo Oksi
    Tytti Vuorinen
    Thijs Feuth
    European Journal of Clinical Microbiology & Infectious Diseases, 2024, 43 : 723 - 734
12345